Aplastic Anemia
Aplastic anemia is a rare and severe hematologic disorder where the bone marrow fails to produce sufficient new blood cells, leading to a deficiency of red blood cells, white blood cells, and platelets. This condition, often arising from immune injury to stem cells in the bone marrow, is potentially fatal if left untreated and is associated with various forms of cancer and cancer syndromes.
Health Outcomes
- Altered Hematology Profile
- Changed Hematology Parameter
- Delayed Onset of Thrombocytopenia
- Developed Anemia
- Improved Blood Index
- Improved Erythroid Response
- Improved Hematological Biomarker
- Improved Hematological Health
- Improved Hematological Measure
- Improved Hematological Parameters
- Improved Hematological Profile
- Improved Iron Metabolism
- Improved Lymphocyte Count
- Improved Survival During Cryopreservation
- Increased Cellular Apoptosis
- Increased GCSF Level
- Increased Infection Frequency
- Maintained Blood-Cell Counts
- No Apoptosis in Host Cells
- Reduced Anemia
- Reduced Antibody Production
- Reduced Bleeding Incidence
- Reduced Complete Blood Count-Derived Inflammatory Parameter Level
- Reduced Erythrocyte Count
- Reduced Gingival Petechiae
- Reduced Granulocyte Levels
- Reduced Hematocrit
- Reduced Hematological Index
- Reduced Immune Protection
- Reduced Leukocyte Count
- Reduced Monocyte Count
- Reduced Neutrophil Count
- Reduced Packed Cell Transfusion
- Reduced Platelet Counts
- Reduced Pulsatility Index
- Reduced Thrombocytopenia
- Reduced Total White Blood Cell Counts
- Reduced Transfusion Rate
- Reduced White Blood Cell Count
- Reduced White Blood Cells After Lead Exposure
- Restored Blood Cell Levels